<DOC>
	<DOCNO>NCT02053142</DOCNO>
	<brief_summary>This prospective study evaluate pharmacokinetics , clinical virologic response acyclovir episodic therapy genital herpes ulcer HIV negative African woman .</brief_summary>
	<brief_title>Acyclovir Therapy Genital Herpes Ulcers HIV Negative African Women</brief_title>
	<detailed_description>This two-part study design measure Area Under Curve ( AUC ) single dose acyclovir 400mg 60 African HIV-negative heterosexual woman history genital ulcer disease ( GUD ) , HSV-2 seropositive HIV-1 seronegative . The study also examine time heal genital lesion duration HSV shed GUD among 90 HIV negative African woman history GUD Herpes Simplex Virus ( HSV ) -2 seropositive HIV-1 seronegative randomize 2:1 ratio receive episodic acyclovir match placebo .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Herpes Genitalis</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>HIV negative determine concordant rapid test HSV2 seropositive ( Focus HerpeSelect EIA &gt; 3.4 ) At least one prior occurrence GUD 18 50 year age Current use , use within past 7 day , acyclovir , valacyclovir , famciclovir Prior hypersensitivity and/or allergic reaction acyclovir Use probenecid , prolongs renal excretion acyclovir Current use , use within past 28 day , investigational agent Currently pregnant nursing Currently plan become pregnant next 3 month Currently consume , average , 7 drink alcohol per week ( Part I ) Current use 20 cigarette daily ( Part I ) Any condition opinion investigator interfere successful completion study procedure .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Herpes simplex virus</keyword>
	<keyword>Genital herpes ulcer</keyword>
</DOC>